Data / Form D filings / SiVEC Biotechnologies, Inc.
SiVEC Biotechnologies, Inc.: Form D filing
SiVEC Biotechnologies, Inc., a biotechnology company in Fort Collins, CO, filed a Form D with the SEC in 2025. The latest, on September 17, 2025, reports $3.3 million sold of a $5.8 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1505 WEST MULBERRY STREET, Fort Collins, CO, 80521
- Phone
- (970) 310-7967
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2085969
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | New notice | $5,800,000 | $3,299,994 | $2,500,006 | 3 | Aug 28, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David A. Sherris | Director | |
| Darcy Mora | Executive Officer, Director | |
| Lyndsey Linke | Executive Officer, Director | |
| Richard A. Freed III | Director | |
| Sibylle A. Hauser | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Sep 15, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SiVEC Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.